bioRxiv · 10.1101/2024.03.06.581777
Development of a new genotype-phenotype linked antibody screening system
Abstract
Antibodies are powerful tools for the therapy and diagnosis of various diseases. In addition to conventional hybridoma-based screening, recombinant antibody-based screening has become a common choice; however, its application is hampered by two factors: 1) screening starts after Ig gene cloning and recombinant antibody production only, and 2) the antibody is composed of paired chains, heavy and light, commonly expressed by two independent expression vectors. Here, we introduce a method for the rapid screening of recombinant monoclonal antibodies by establishing a Golden Gate-based dual-expression vector and in-vivo expression of membrane-bound antibodies. Using this system, we demonstrate the rapid isolation of influenza cross-reactive antibodies with high affinity from immunized mice within 7 days. This system is particularly useful for isolating therapeutic or diagnostic antibodies, e.g., during foreseen pandemics. Impact StatementA Golden Gate-based dual-expression vector enables rapid screening, which facilitates efficient isolation of high-affinity cross-reactive antibodies for therapeutic or diagnostic use and provides a crucial advance for pandemic preparedness.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Watanabe, T., Hata, H., Mochizuki, Y., Yokoyama, F., Hasegawa, T., Kumar, N., Kurosaki, T., Ohara, O., Fukuyama, H.. 2024-03-08. Development of a new genotype-phenotype linked antibody screening system. https://doi.org/10.1101/2024.03.06.581777
Cite the original work for its findings. Save a collection to share your selection of sources.